Need free advice? Get in touch

0800 038 6767 | Live Chat

Nivolumab – New immunotherapy drug could treat mesothelioma, the cancer caused by asbestos

A new immunotherapy drug is currently being tested on 300 British patients. The new treatment has already been used for several other types of malignant tumour, but it is hoped that it will be an […]

Posted on 17th July 2017 Read More >

Hope for mesothelioma patients

A new drug has been developed in a laboratory in Melbourne, Australia, which has seen cancer tumours being shrunk.  The next phase of the research is to undertake human trials to assess the drug’s benefits […]

Posted on 09th May 2017 Read More >

Can the thickness of a mesothelioma tumour highlight a patient’s treatment options?

A recent study conducted in the European Respiratory Journal, titled ‘Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma’, has pointed the way to help consultants determine the most […]

Posted on 04th May 2017 Read More >

Immunotherapy for pleural mesothelioma – is this the answer?

Recent developments in medical science have resulted in the wide use of immunotherapy as an emerging tool in tackling various forms of cancer, but its effectiveness in combatting asbestos related mesothelioma, remains in the balance. […]

Posted on 07th April 2017 Read More >

Uneven drug distribution may account for poor treatment responses

A new imaging technique which visualises how a drug spreads through a tumour, has shown that the cancer drug, Taxol, is unevenly distributed through pleural mesothelioma. It is thought that this may be why mesothelioma […]

Posted on 04th April 2017 Read More >

Positive news from mesothelioma clinical trial

Boehringer Ingelheim, a pharmaceutical company has presented information about a study they have been conducting, to evaluate the safety and efficacy of a drug, nintedanib when combined with pemetrexed and ciplatin, to treat pleural mesothelioma. […]

Posted on 19th January 2017 Read More >

Sea cucumbers could fight mesothelioma

An active agent found in Caribbean sea cucumbers has already started to be used in the treatment of ovarian cancer and researchers believe it could be effective in the treatment of mesothelioma. A study conducted […]

Posted on 10th January 2017 Read More >

What new treatment options are currently taking place for mesothelioma patients?

Clinical trials Clinical trials are medical trials which compare the effects of one medical treatment with another. They help doctors understand how to treat a particular disease or condition. If you take part in a […]

Posted on 08th November 2016 Read More >

Specialised mesothelioma treatment could improve survival rates

It is widely known that chemotherapy treatment known as pemetrexed (Alimta) is the only drug which has been approved in the treatment of asbestos related mesothelioma and is regularly used in league with a platinum […]

Posted on 02nd August 2016 Read More >

Claims Calculator

Add your details below to calculate your claim

Your compensation award could be:

To receive a thorough and individual assessment, please contact us on 0800 038 6767

*The above figure is only an estimate of the value of the claim for your condition and is based on the Judicial College guidelines, with an additional amount for care and assistance. In addition there will be a claim for loss of income/financial dependency along with any travelling and miscellaneous expenses which will increase the value of your claim further. You may also be entitled to relevant state benefits. For further information on the value of claims or your entitlement to state benefits, please contact us on 0800 038 6767.


Please wait